Machine learning application for prediction of locoregional recurrences in early oral tongue cancer: a Web-based prognostic tool.

Journal: Virchows Archiv : an international journal of pathology
Published Date:

Abstract

Estimation of risk of recurrence in early-stage oral tongue squamous cell carcinoma (OTSCC) remains a challenge in the field of head and neck oncology. We examined the use of artificial neural networks (ANNs) to predict recurrences in early-stage OTSCC. A Web-based tool available for public use was also developed. A feedforward neural network was trained for prediction of locoregional recurrences in early OTSCC. The trained network was used to evaluate several prognostic parameters (age, gender, T stage, WHO histologic grade, depth of invasion, tumor budding, worst pattern of invasion, perineural invasion, and lymphocytic host response). Our neural network model identified tumor budding and depth of invasion as the most important prognosticators to predict locoregional recurrence. The accuracy of the neural network was 92.7%, which was higher than that of the logistic regression model (86.5%). Our online tool provided 88.2% accuracy, 71.2% sensitivity, and 98.9% specificity. In conclusion, ANN seems to offer a unique decision-making support predicting recurrences and thus adding value for the management of early OTSCC. To the best of our knowledge, this is the first study that applied ANN for prediction of recurrence in early OTSCC and provided a Web-based tool.

Authors

  • Rasheed Omobolaji Alabi
    Department of Industrial Digitalization, School of Technology and Innovations, University of Vaasa, Vaasa, Finland.
  • Mohammed Elmusrati
    Department of Industrial Digitalization, School of Technology and Innovations, University of Vaasa, Vaasa, Finland.
  • Iris Sawazaki-Calone
    Oral Pathology and Oral Medicine, Dentistry School, Western Parana State University, Cascavel, PR, Brazil.
  • Luiz Paulo Kowalski
    Department of Head and Neck Surgery and Otorhinolaryngology, AC Camargo Cancer Center, Sao Paulo, Brazil.
  • Caj Haglund
    Research Programs Unit, Translational Cancer Biology, University of Helsinki, Helsinki, Finland.
  • Ricardo D Coletta
    Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba, São Paulo, Brazil.
  • Antti A Mäkitie
    Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Tuula Salo
    Department of Pathology, University of Helsinki, Helsinki, Finland.
  • Ilmo Leivo
    Institute of Biomedicine, Pathology, University of Turku, Turku, Finland.
  • Alhadi Almangush
    Research Programme in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland. alhadi.almangush@helsinki.fi.